Modulation of TRPA1 in RA patients was associated with CD14+ cell activation and higher numbers of circulating neutrophils, effects that might contribute to pain and disability in RA patients as the leukocytes populating the joints would amplify the proalgesic process [92]. The gene discussed is CD14; the disease is rheumatoid arthritis.